Cholelithiasis in patients treated with Glucagon-Like Peptide-1 Receptor: An updated meta-analysis of randomized controlled trials.
Glucagon-Like Peptide-1 Receptor Agonists
Meta-analysis
Journal
Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
14
11
2019
revised:
13
02
2020
accepted:
17
02
2020
pubmed:
23
2
2020
medline:
27
6
2020
entrez:
22
2
2020
Statut:
ppublish
Résumé
Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) has been associated with cholelithiasis in a previous meta-analysis. The publication of new trials suggests the need for an update. We collected trials with GLP1-RA vs. other therapies, calculating Mantel-Haenszel odds ratio (MH-OR, 95%CI). GLP1-RA significantly increased the risk of cholelithiasis (MH-OR 1.28 [1.11, 1.48]).
Identifiants
pubmed: 32084455
pii: S0168-8227(19)31645-6
doi: 10.1016/j.diabres.2020.108087
pii:
doi:
Substances chimiques
Glucagon-Like Peptide-1 Receptor
0
Hypoglycemic Agents
0
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
108087Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.